PI
EW icon

PEAK6 Investments’s Edwards Lifesciences EW Stock Holding History

PEAK6 Investments’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$7.23M Sell
109,500
-23,100
-17% -$1.68M 0.02% 737
2024
Q2 		$12.2M Sell
132,600
-7,600
-5% -$673K 0.03% 422
2024
Q1 		$13.4M Buy
140,200
+70,500
+101% +$5.92M 0.04% 405
2023
Q4 		$5.31M Sell
69,700
-10,600
-13% -$738K 0.02% 800
2023
Q3 		$5.56M Sell
80,300
-7,100
-8% -$571K 0.03% 658
2023
Q2 		$8.24M Buy
87,400
+63,800
+270% +$5.55M 0.04% 435
2023
Q1 		$1.95M Buy
23,600
+1,900
+9% +$149K 0.01% 1322
2022
Q4 		$1.62M Buy
21,700
+21,100
+3,517% +$1.63M 0.01% 1516
2022
Q3 		$50K Sell
600
-88,400
-99% -$8.51M ﹤0.01% 4349
2022
Q2 		$8.4M Buy
89,000
+75,000
+536% +$7.76M 0.02% 965
2022
Q1 		$1.65M Sell
14,000
-22,000
-61% -$2.47M ﹤0.01% 2032
2021
Q4 		$4.66M Buy
36,000
+25,300
+236% +$2.95M 0.01% 1180
2021
Q3 		$1.21M Sell
10,700
-19,800
-65% -$2.26M ﹤0.01% 2431
2021
Q2 		$3.16M Buy
30,500
+23,500
+336% +$2.22M 0.01% 1473
2021
Q1 		$585K Sell
7,000
-19,900
-74% -$1.68M ﹤0.01% 3053
2020
Q4 		$2.45M Sell
26,900
-66,200
-71% -$5.49M 0.01% 1685
2020
Q3 		$7.43M Buy
93,100
+47,400
+104% +$3.7M 0.02% 739
2020
Q2 		$3.16M Buy
45,700
+31,900
+231% +$2.27M 0.01% 1128
2020
Q1 		$868K Sell
13,800
-140,700
-91% -$10.1M 0.01% 1633
2019
Q4 		$12M Sell
154,500
-44,400
-22% -$3.47M 0.06% 322
2019
Q3 		$14.6M Buy
198,900
+43,200
+28% +$3.03M 0.09% 233
2019
Q2 		$9.59M Buy
155,700
+75,600
+94% +$4.57M 0.06% 379
2019
Q1 		$5.11M Sell
80,100
-47,700
-37% -$2.72M 0.03% 698
2018
Q4 		$6.53M Buy
127,800
+21,900
+21% +$1.11M 0.04% 506
2018
Q3 		$6.15M Buy
+105,900
New +$5.18M 0.03% 683

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

PEAK6 Investments's EW Position: Q3 2024 in Review

PEAK6 Investments increased its Edwards Lifesciences (EW) stake by 504% in Q3 2024, buying an estimated $2.93M and bringing the position to 48,322 shares worth $3.19M. The position accounts for 0.01% of the portfolio, ranked #1202.

PEAK6 Investments first reported a position in EW in Q4 2018 and has held it in 13 quarters since. The position peaked at $5.01M in Q1 2022. 1,193 funds tracked by Wall St. Rank hold EW as of Q3 2024.

  • PEAK6 Investments held 48,322 shares of Edwards Lifesciences worth $3.19M as of Q3 2024.
  • PEAK6 Investments bought 40,325 Edwards Lifesciences shares in Q3 2024, an estimated $2.93M.
  • Edwards Lifesciences made up 0.01% of PEAK6 Investments's portfolio in Q3 2024, its #1202 holding.
  • PEAK6 Investments first reported a position in Edwards Lifesciences in Q4 2018 and has held it in 13 quarters since.
  • PEAK6 Investments's Edwards Lifesciences position peaked at $5.01M in Q1 2022.
  • 1,193 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.